ClearCount Medical Solutions, Inc. (Acquired by a publicly-traded medical device company)
ClearCount Medical Solutions is a medical device company focused on patient safety solutions. ClearCount has assembled an extendable RFID-based platform that provides a comprehensive solution to improve efficiency while preventing medical errors. ClearCount’s SmartSponge®, SmartWand-DTX, and SmartSponge Flex systems are the only RFID-enabled systems for counting and detecting surgical sponges, thereby improving patient and Operating Room safety, enhancing productivity, and reducing cost. ClearCount has also advanced its proprietary RFID platform to include a unique on-metal RFID tag for surgical instrumentation tracking.
Hability is the Patient Relationship Management platform for outpatient medicine, supporting patient follow-up over the phone, text, and email. Medical professionals use Hability to improve communication with patients between visits to the clinic, helping to form strong and lasting relationships between patients and providers. By supporting these relationships, Hability is helping practitioners treat more patients, helping patients heal better from injuries and illness, and making medicine personal again.
Health Monitoring Systems, Inc.
Health Monitoring Systems is a pioneer in community health surveillance. The company maintains online networks to collect data from hospitals and other healthcare providers, and then offers analytics of the aggregated information to detect, pinpoint and understand real-time and emerging health and safety issues. Clients include public health authorities, hospitals and others in the healthcare industry.
Immunetrics is a bio-simulation company, founded in 2001, that specializes in in silico disease modeling. Immunetrics modeling technology provides critical information to drug developers to accelerate and improve the drug discovery and development process, particularly in the identification of clinically relevant biomarkers. Immunetrics has developed a predictive software model of the human response to inflammation and coagulation, which enables drug discovery and development firms to gain comprehensive insights into a compound before investing significant resources into time-intensive and costly animal testing and human clinical trials.
Mobile Aspects, Inc.
Mobile Aspects provides advanced item level tracking, inventory and accountability applications using Radio Frequency (RFID) technology for the healthcare delivery arena. Their initial product, InviRT (Inventory in Real Time) provides healthcare delivery organizations with real time transparency into the location, inventory level, and the last person to move their valuable supplies and medications at all times. The Healthcare Industry has been under increasing pressure to reduce errors in their processes, which cost the industry in excess of $50 Billion per year. Further, the entire industry is being encouraged by HMO’s and the government to significantly reduce costs, while, at the same time, improving security and accountability for high-cost, high-sensitivity items. Mobile Aspects partners with hardware suppliers, enterprise database vendors, and equipment supply companies to provide healthcare delivery organizations with an item tracking solution that monitors each item’s movement from supply room to end use. This helps health organizations to be more efficient, eliminate costly errors, and provide employee accountability.
Pratter reduces the incredible in-network pricing variation for blood work, imaging studies and elective medical procedures that make up 80% of a company’s medical spend. We leverage self-insured company cost data by 1) medical cost savings analyses to monitor 600 of the most common outpatient medical cost items and 2) uploading it to pratter.us to search and save on medical care by zip code before the care is received.
SpectraGenetics is an innovative gene tagging company providing proprietary and breakthrough technologies for drug discovery and development. These technologies allow researchers to accurately determine when a gene is expressed and to visualize in real time the expression, cellular localization or activation of proteins in living cells. This information has the potential to transform the drug discovery and development process by providing significant productivity improvements in identifying suitable targets and leads for therapeutic development.
Treatspace builds and installs software systems that power secure health networks for medical practices, hospitals, medical-related organizations. Market growth for Treatspace health networks is driven by ACA, HITECH and HIPAA legislation. As hospitals rapidly acquire physician practices, they must grow patient volume, maximize reimbursement and prevent both penalties and referral leakage within the system to remain competitive. Treatspace networks operate standalone or atop legacy systems.